Martindale Pharma improves Aurum pre-filled syringe packaging

Published: 9-Nov-2011
Packaging Regulatory

To ensure ease of use and improve patient safety

Martindale Pharma, a UK manufacturer and supplier of pharmaceutical specials, has made a number of improvements to its Aurum range of 11 pre-filled syringes.

The Aurum syringes are used for on-the-spot administration of drugs where high visibility and simple drug identification is crucial.

The Brentwood, Essex-based firm has redesigned the range to enhance ease of use and help improve patient safety. Specific improvements include new colour-differentiated packaging; colour-differentiated translucent boxes that confirm contents; and colour-differentiated labels. In addition the firm has improved tamper-evident labels and the packaging is latex-free and Luer Lock fitting.

The firm says its new colour-differentiated packaging meets national and international colour differentiation standards on syringe labelling and also the Royal College of Anaesthetists recommendations on syringe labelling in critical care.

  • Companies:
  • Martindale Pharma
See more

You may also like

Packaging

SCHOTT Pharma delivers strong second quarter of fiscal year 2025

Read more
SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today published its results for the second quarter of the fiscal year 2025

Trending Articles

  1. SGS to deliver ENERGY STAR certification for medical imaging equipment SGS is proud to have gained approval from the US Environmental Protection Agency (EPA) to expand its scope as a recognised third-party certification body (CB) for ENERGY STAR
  2. Bosch Packaging Technology reports stable sales development in 2017 The Bosch subsidiary made the announcement at this year's ACHEMA trade show, which is taking place this week
  3. Chinese medicine research programme a success says Brussels The project helped develop a European-Chinese network for collaborating on functional genomics research, among other things
  4. Executing a successful remediation program: part 1 of 3 This 3-part series looks at what companies need to do to ensure that they have a successful remediation program
  5. Brecon names Charles Evans as operations director Joins QA and regulatory affairs director Kay O’Hagan from client side of business

Upcoming event

CPhI North America

20–22 May 2025 | Exhibition | Pennsylvania, US See all

You may also like

Packaging

SCHOTT Pharma delivers strong second quarter of fiscal year 2025

SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today published its results for the second quarter of the fiscal year 2025
Sustainability

SGS to deliver ENERGY STAR certification for medical imaging equipment

SGS is proud to have gained approval from the US Environmental Protection Agency (EPA) to expand its scope as a recognised third-party certification body (CB) for ENERGY STAR
Packaging

Schreiner MediPharm debuts new digital labels for clinical trials

The technology has the potential to replace conventional labels by electronic ones with digital displays in the future
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Why the IVDR preapplication process matters for legacy manufacturers

For many in vitro diagnostic device (IVD) manufacturers, the first direct interaction with regulators comes through a Notified Body (NB) under Regulation (EU) 2017/746 (IVDR). Understanding the NB’s role, responsibilities and processes is essential … especially for legacy manufacturers transitioning from pre-IVDR certifications
Manufacturing

ACG Packaging Materials' sustainability targets given the SBTi green light

ACG will commit to reducing its scope 1, 2 and 3 GHG emissions to reduce its environmental impact and improve its sustainability credentials
Regulatory

FDA to get foreign manufacturing inspections "back on track" with new inspection scheme

The inspection scheme means that foreign pharmaceutical and medical product manufacturers will be subject to unannounced inspections by the US regulator
Distribution

DFE Pharma achieves ISO 22301 certification for BCMS

DFE Pharma's Business Continuity Management System (BCMS) at its head office in Goch, Germany helps it to effectively maintain its operations
Subscribe now